These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7064206)

  • 1. A prospective study of platelet-transfusion therapy administered to patients with acute leukemia.
    Kutti J; Zaroulis CG; Dinsmore RE; Reich L; Clarkson BD; Good RA
    Transfusion; 1982; 22(1):44-7. PubMed ID: 7064206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and laboratory correlates of platelet alloimmunization and refractoriness in the PLADO trial.
    Hess JR; Trachtenberg FL; Assmann SF; Triulzi DJ; Kaufman RM; Strauss RG; Granger S; Slichter SJ
    Vox Sang; 2016 Oct; 111(3):281-291. PubMed ID: 27185561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloimmunization following prophylactic granulocyte transfusion.
    Schiffer CA; Aisner J; Daly PA; Schimpff SC; Wiernik PH
    Blood; 1979 Oct; 54(4):766-74. PubMed ID: 476300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components--a randomized trial.
    Oksanen K; Kekomäki R; Ruutu T; Koskimies S; Myllylä G
    Transfusion; 1991 Sep; 31(7):588-94. PubMed ID: 1891788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up patients with leukemia receiving platelet transfusions: identification of a large group of patients who do not become alloimmunized.
    Dutcher JP; Schiffer CA; Aisner J; Wiernik PH
    Blood; 1981 Nov; 58(5):1007-11. PubMed ID: 6794674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that circulating immune complexes remove transfused platelets from the circulation.
    Kutti J; Zaroulis CG; Safai-Kutti S; Dinsmore RE; Day NK; Good RA
    Am J Hematol; 1981 Nov; 11(3):255-9. PubMed ID: 7315840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloimmunization following platelet transfusions in patients with acute nonlymphocytic leukemia.
    Nozaki H; Shimizu M; Komatsuda M; Watanabe K; Nagao T; Arimori S
    Tokai J Exp Clin Med; 1986 Aug; 11(3):201-4. PubMed ID: 3475819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness.
    Seftel MD; Growe GH; Petraszko T; Benny WB; Le A; Lee CY; Spinelli JJ; Sutherland HJ; Tsang P; Hogge DE
    Blood; 2004 Jan; 103(1):333-9. PubMed ID: 12958065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet transfusion therapy in acute leukemia: lack of effect of splenomegaly on transfusion requirements and risk of hemorrhage.
    Witzig TE; Ducatman BS; Wick MR; Letendre L; Moore SB; Ilstrup DM; Taswell HF
    Am J Hematol; 1985 Apr; 18(4):345-50. PubMed ID: 3976647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness.
    Brouk H; Bertrand G; Zitouni S; Djenouni A; Martageix C; Griffi F; Kaplan C; Ouelaa H
    Transfus Apher Sci; 2015 Jun; 52(3):295-9. PubMed ID: 25620758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of refractoriness and HLA-alloimmunization using filtered blood products.
    Sniecinski I; O'Donnell MR; Nowicki B; Hill LR
    Blood; 1988 May; 71(5):1402-7. PubMed ID: 3282572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prestorage leukocyte depletion is not necessarily required for the prevention of refractoriness to platelet transfusion.
    de Wolf J; Westerterp A; Smit Sibinga C; Halie MR
    Blood; 1995 Oct; 86(8):3263-4. PubMed ID: 7579424
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictive value of enzyme-linked immunoassay platelet crossmatching for transfusion of platelet concentrates to alloimmunized recipients.
    Brubaker DB; Duke JC; Romine M
    Am J Hematol; 1987 Apr; 24(4):375-87. PubMed ID: 3551590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients.
    Messerschmidt GL; Makuch R; Appelbaum F; Ungerleider RS; Abrams R; O'Donnell J; Holohan TV; Fontana J; Wright D; Anagnou NP
    Cancer; 1988 Aug; 62(4):795-801. PubMed ID: 3293762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL.
    Heckman KD; Weiner GJ; Davis CS; Strauss RG; Jones MP; Burns CP
    J Clin Oncol; 1997 Mar; 15(3):1143-9. PubMed ID: 9060557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet refractoriness and alloimmunization in pediatric oncology and bone marrow transplant patients.
    Hogge DE; McConnell M; Jacobson C; Sutherland HJ; Benny WB; Massing BG
    Transfusion; 1995 Aug; 35(8):645-52. PubMed ID: 7631404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of platelet alloimmunization.
    Slichter SJ
    Prog Clin Biol Res; 1986; 211():83-116. PubMed ID: 3515365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttransfusion purpura following bone marrow transplantation.
    Evenson DA; Stroncek DF; Pulkrabek S; Perry EH; Radford J; Miller JS; Verfaillie C
    Transfusion; 1995 Aug; 35(8):688-93. PubMed ID: 7631411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloimmunization following platelet transfusion: the absence of a dose-response relationship.
    Dutcher JP; Schiffer CA; Aisner J; Wiernik PH
    Blood; 1981 Mar; 57(3):395-8. PubMed ID: 7459428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.